Novel Immunotherapeutic Approaches to the Treatment of Cancer
-15%
portes grátis
Novel Immunotherapeutic Approaches to the Treatment of Cancer
Drug Development and Clinical Application
Rennert, Paul D.
Springer International Publishing AG
05/2018
276
Mole
Inglês
9783319806624
15 a 20 dias
4394
Descrição não disponível.
Introduction.- Enhancing the
efficacy of checkpoint blockade through combination therapies.- Novel
Immunomodulatory Targets in the Immunoglobulin-Superfamily.- Parallel Costimulation
of Effector and Regulatory T Cells by OX40, GITR, TNFRSF25, CD27 and CD137.- NK Cell Responses
in Immunotherapy.- Reversing T cell
dysfunction for tumor immunotherapy.- Immunomodulation
within a single tumor site to induce systemic anti-tumor immunity.- Novel Targets and
Their Assessment for Cancer Treatment.- The New Frontier
of Antibody Drug Conjugates.- Cellular
Therapies.- Targeting the
Physicochemical, Cellular, and Immunosuppressive Properties of the Tumor
Microenvironment by Depletion of Hyaluronan to Treat Cancer.
efficacy of checkpoint blockade through combination therapies.- Novel
Immunomodulatory Targets in the Immunoglobulin-Superfamily.- Parallel Costimulation
of Effector and Regulatory T Cells by OX40, GITR, TNFRSF25, CD27 and CD137.- NK Cell Responses
in Immunotherapy.- Reversing T cell
dysfunction for tumor immunotherapy.- Immunomodulation
within a single tumor site to induce systemic anti-tumor immunity.- Novel Targets and
Their Assessment for Cancer Treatment.- The New Frontier
of Antibody Drug Conjugates.- Cellular
Therapies.- Targeting the
Physicochemical, Cellular, and Immunosuppressive Properties of the Tumor
Microenvironment by Depletion of Hyaluronan to Treat Cancer.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Cellular Therapy;Drug Development;Immunotherapy;Oncology;Cancer
Introduction.- Enhancing the
efficacy of checkpoint blockade through combination therapies.- Novel
Immunomodulatory Targets in the Immunoglobulin-Superfamily.- Parallel Costimulation
of Effector and Regulatory T Cells by OX40, GITR, TNFRSF25, CD27 and CD137.- NK Cell Responses
in Immunotherapy.- Reversing T cell
dysfunction for tumor immunotherapy.- Immunomodulation
within a single tumor site to induce systemic anti-tumor immunity.- Novel Targets and
Their Assessment for Cancer Treatment.- The New Frontier
of Antibody Drug Conjugates.- Cellular
Therapies.- Targeting the
Physicochemical, Cellular, and Immunosuppressive Properties of the Tumor
Microenvironment by Depletion of Hyaluronan to Treat Cancer.
efficacy of checkpoint blockade through combination therapies.- Novel
Immunomodulatory Targets in the Immunoglobulin-Superfamily.- Parallel Costimulation
of Effector and Regulatory T Cells by OX40, GITR, TNFRSF25, CD27 and CD137.- NK Cell Responses
in Immunotherapy.- Reversing T cell
dysfunction for tumor immunotherapy.- Immunomodulation
within a single tumor site to induce systemic anti-tumor immunity.- Novel Targets and
Their Assessment for Cancer Treatment.- The New Frontier
of Antibody Drug Conjugates.- Cellular
Therapies.- Targeting the
Physicochemical, Cellular, and Immunosuppressive Properties of the Tumor
Microenvironment by Depletion of Hyaluronan to Treat Cancer.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
